This reports aims to provide analyses of the use of Real World Evidence trials whilst identifying global trends over the years.
Real-World Evidence (RWE) trials are crucial for further understanding newly approved medicinal products in the real-world setting. These trials provide clinical evidence of the long-term safety and efficacy of these drugs from real-world data where patients are treated using these drugs. RWE trials mainly involve observational data outside the traditional involvement of randomized controlled trials. Using real-world data is an integral part of RWE trials as it allows researchers to monitor and assess patient outcomes and treatment methods. It also allows for the effects of a medicinal product to be investigated over a long period of time.
Real-World Evidence (RWE) trials are crucial for further understanding newly approved medicinal products in the real-world setting. These trials provide clinical evidence of the long-term safety and efficacy of these drugs from real-world data where patients are treated using these drugs. RWE trials mainly involve observational data outside the traditional involvement of randomized controlled trials. Using real-world data is an integral part of RWE trials as it allows researchers to monitor and assess patient outcomes and treatment methods. It also allows for the effects of a medicinal product to be investigated over a long period of time.
Scope
- The clinical trials data used for these analyses were extracted from the analyst's Clinical Trials Database.
- The report focuses on RWE trials where the data was sourced from the clinical trial database and all clinical trials were initiated between 2001 to 2021.
- The data have been analyzed by year, phase, status, therapy area, indication, geography, sponsor type (top industry sponsors versus non-industry sponsors), and reasons for discontinuation.
- In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.
Reasons to Buy
- Understand how RWE trials are beneficial
- The trends of RWE clinical trials
- Global uptake and usage of RWE trials
Table of Contents
Executive SummaryIntroduction
Clinical Trials Landscape of Real-World Evidence Trials
Key Findings
Appendix
List of Tables
Table 1: RWE Trials by Drugs
Table 2: Post Marketing Commitments
Table 3: RWE Developments by Regulatory Agencies
List of Figures
Figure 1: Number of RWE Trials by Sponsor Type and Year
Figure 2: RWE Trials by Phase and Status
Figure 3: RWE Trials by Regional Distribution
Figure 4: Single-Country & Multinational Real-World Evidence Trials by Region
Figure 5: Distribution of RWE Trials by Top 5 Countries
Figure 6: RWE Trials by Therapy Area
Figure 7: RWE Trials by Indication
Figure 8: Reasons for Trial Discontinuation of RWE Trials
Figure 9: Top Industry Sponsors for RWE Trials
Figure 10: Top Non - Industry Sponsors for RWE Trials
Figure 11: Virtual Trial Components
Figure 12: RWE with Virtual Trial Component by Therapy Area
Figure 13: Device Layers
